Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Roles of natural killer cells in antiviral immunity.
Waggoner SN, Reighard SD, Gyurova IE, Cranert SA, Mahl SE, Karmele EP, McNally JP, Moran MT, Brooks TR, Yaqoob F, Rydyznski CE. Waggoner SN, et al. Among authors: brooks tr. Curr Opin Virol. 2016 Feb;16:15-23. doi: 10.1016/j.coviro.2015.10.008. Epub 2015 Nov 16. Curr Opin Virol. 2016. PMID: 26590692 Free PMC article. Review.
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.
Markowitz J, Brooks TR, Duggan MC, Paul BK, Pan X, Wei L, Abrams Z, Luedke E, Lesinski GB, Mundy-Bosse B, Bekaii-Saab T, Carson WE 3rd. Markowitz J, et al. Among authors: brooks tr. Cancer Immunol Immunother. 2015 Feb;64(2):149-59. doi: 10.1007/s00262-014-1618-8. Epub 2014 Oct 11. Cancer Immunol Immunother. 2015. PMID: 25305035 Free PMC article.
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.
Duggan MC, Jochems C, Donahue RN, Richards J, Karpa V, Foust E, Paul B, Brooks T, Tridandapani S, Olencki T, Pan X, Lesinski GB, Schlom J, Carson Iii WE. Duggan MC, et al. Cancer Immunol Immunother. 2016 Nov;65(11):1353-1364. doi: 10.1007/s00262-016-1893-7. Epub 2016 Aug 31. Cancer Immunol Immunother. 2016. PMID: 27581603 Free PMC article. Clinical Trial.
A phase I trial of bortezomib and interferon-α-2b in metastatic melanoma.
Markowitz J, Luedke EA, Grignol VP, Hade EM, Paul BK, Mundy-Bosse BL, Brooks TR, Dao TV, Kondalasula SV, Lesinski GB, Olencki T, Kendra KL, Carson WE 3rd. Markowitz J, et al. Among authors: brooks tr. J Immunother. 2014 Jan;37(1):55-62. doi: 10.1097/CJI.0000000000000009. J Immunother. 2014. PMID: 24316557 Free PMC article. Clinical Trial.
MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches.
Markowitz J, Abrams Z, Jacob NK, Zhang X, Hassani JN, Latchana N, Wei L, Regan KE, Brooks TR, Uppati SR, Levine KM, Bekaii-Saab T, Kendra KL, Lesinski GB, Howard JH, Olencki T, Payne PR, Carson WE 3rd. Markowitz J, et al. Among authors: brooks tr. Onco Targets Ther. 2016 Sep 29;9:5931-5941. doi: 10.2147/OTT.S106288. eCollection 2016. Onco Targets Ther. 2016. PMID: 27729802 Free PMC article.
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.
Markowitz J, Wang J, Vangundy Z, You J, Yildiz V, Yu L, Foote IP, Branson OE, Stiff AR, Brooks TR, Biesiadecki B, Olencki T, Tridandapani S, Freitas MA, Papenfuss T, Phelps MA, Carson WE. Markowitz J, et al. Among authors: brooks tr. Sci Rep. 2017 Nov 13;7(1):15424. doi: 10.1038/s41598-017-14970-0. Sci Rep. 2017. PMID: 29133913 Free PMC article.
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
Suarez-Kelly LP, Levine KM, Olencki TE, Del Campo SEM, Streacker EA, Brooks TR, Karpa VI, Markowitz J, Bingman AK, Geyer SM, Kendra KL, Carson WE. Suarez-Kelly LP, et al. Among authors: brooks tr. Cancer Immunol Immunother. 2019 Apr;68(4):619-629. doi: 10.1007/s00262-019-02308-w. Epub 2019 Feb 6. Cancer Immunol Immunother. 2019. PMID: 30725205 Free PMC article. Clinical Trial. No abstract available.
Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.
Markowitz J, Wang J, Vangundy Z, You J, Yildiz V, Yu L, Foote IP, Branson OE, Stiff AR, Brooks TR, Biesiadecki B, Olencki T, Tridandapani S, Freitas MA, Papenfuss T, Phelps MA, Carson WE. Markowitz J, et al. Among authors: brooks tr. Sci Rep. 2018 Mar 6;8(1):4203. doi: 10.1038/s41598-018-21306-z. Sci Rep. 2018. PMID: 29511220 Free PMC article.
Myeloid-derived suppressor cells in breast cancer.
Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, Carson WE 3rd. Markowitz J, et al. Among authors: brooks tr. Breast Cancer Res Treat. 2013 Jul;140(1):13-21. doi: 10.1007/s10549-013-2618-7. Epub 2013 Jul 5. Breast Cancer Res Treat. 2013. PMID: 23828498 Free PMC article. Review.
27 results